Arcadia Biosciences Inc (RKDA.OQ)
RKDA.OQ on NASDAQ Stock Exchange Capital Market
7.26USD
16 Jul 2018
7.26USD
16 Jul 2018
Change (% chg)
$-0.15 (-2.02%)
$-0.15 (-2.02%)
Prev Close
$7.41
$7.41
Open
$7.36
$7.36
Day's High
$7.55
$7.55
Day's Low
$7.22
$7.22
Volume
15,614
15,614
Avg. Vol
158,346
158,346
52-wk High
$66.42
$66.42
52-wk Low
$3.60
$3.60
About
Arcadia Biosciences, Inc. is an agricultural biotechnology trait company. The Company develops a portfolio of yield and traits addressing multiple crops that supply the global food and feed markets. It has a pipeline of products in development incorporating its traits, including products that are in advanced stages of developmen... (more)
Overall
| Beta: | -- |
| Market Cap(Mil.): | $14.21 |
| Shares Outstanding(Mil.): | 42.66 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| RKDA.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 23.47 | 359.87 |
| EPS (TTM): | -0.41 | -- | -- |
| ROI: | -35.03 | 2.17 | 10.74 |
| ROE: | -78.63 | 4.11 | 13.94 |
BRIEF-Arcadia Biosciences Q1 Revenue Fell 79 Percent To $214,000
* ARCADIA BIOSCIENCES ANNOUNCES FIRST-QUARTER 2018 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS
BRIEF-Arcadia Biosciences Files Prospectus Related To Sale Of Up To 2.9 Mln Shares Of Common Stock By Selling Shareholders
* ARCADIA BIOSCIENCES FILES PROSPECTUS RELATED TO SALE OF UP TO 2.9 MILLION SHARES OF COMMON STOCK BY SELLING SHAREHOLDERS - SEC FILING Source text: (https://bit.ly/2uyTUPD) Further company coverage:
BRIEF-Arcadia Biosciences Welcomes New Chief Commercial Officer
* ARCADIA BIOSCIENCES - SARAH REITER JOINED CO'S EXECUTIVE TEAM AS CHIEF COMMERCIAL OFFICER Source text for Eikon: Further company coverage:
BRIEF-Arcadia Biosciences Announces $10 Mln Private Placement
* ARCADIA BIOSCIENCES ANNOUNCES $10 MILLION PRIVATE PLACEMENT
Estimates